Effects of the M1 Agonist Xanomeline on Processing of Human β-Amyloid Precursor Protein (FAD, Swedish Mutant) Transfected into Chinese Hamster Ovary-m1 Cells
- 1 March 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 244 (1) , 156-160
- https://doi.org/10.1006/bbrc.1998.8235
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cellsLife Sciences, 1995
- Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptidePublished by Elsevier ,1993
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridinesJournal of Medicinal Chemistry, 1992
- Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein PrecursorScience, 1992
- A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's DiseaseScience, 1991
- Evidence that β-Amyloid Protein in Alzheimer's Disease Is Not Derived by Normal ProcessingScience, 1990
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 1987